NEW YORK, April 23, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of e.l.f. Beauty, Inc. (“Elf”) (NYSE: ELF) between November 1, 2023 and November 19, 2024, both dates inclusive (the “Class Period”), of the important May 5, 2025 lead plaintiff deadline. So what: If you… Continue reading ELF Investors Have Opportunity to Lead e.l.f. Beauty, Inc. Securities Fraud Lawsuit
Tag: M and A
APP Investors Have Opportunity to Lead AppLovin Corporation Securities Fraud Lawsuit
NEW YORK, April 23, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AppLovin Corporation (NASDAQ: APP) between May 10, 2023 and February 25, 2025, both dates inclusive (the “Class Period”), of the important May 5, 2025 lead plaintiff deadline. So What: If you purchased AppLovin securities… Continue reading APP Investors Have Opportunity to Lead AppLovin Corporation Securities Fraud Lawsuit
TBBK Investors Have Opportunity to Lead The Bancorp, Inc. Securities Fraud Lawsuit
NEW YORK, April 23, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of The Bancorp, Inc. (NASDAQ: TBBK) between January 25, 2024 and March 4, 2025, inclusive (the “Class Period”), of the important May 16, 2025 lead plaintiff deadline. So what: If you purchased The Bancorp securities… Continue reading TBBK Investors Have Opportunity to Lead The Bancorp, Inc. Securities Fraud Lawsuit
Gold Royalty Announces First Quarter 2025 Preliminary Results
VANCOUVER, BC, April 23, 2025 /PRNewswire/ – Gold Royalty Corp. (“Gold Royalty” or the “Company”) (NYSE American: GROY) is pleased to announce first quarter 2025 preliminary results as well as details related to its first quarter results date, details of its first quarter earnings call and its upcoming capital markets day. All amounts are expressed in U.S.… Continue reading Gold Royalty Announces First Quarter 2025 Preliminary Results
International Exhibits Solutions to Simplify the Customer Experience at ACT Expo 2025
ANAHEIM, Calif., April 23, 2025 /PRNewswire/ — International Motors, LLC * (“International”) will showcase its digitally enabled solutions dedicated to the customer experience at ACT Expo 2025 in Anaheim, California April 28 – May 1. Continue Reading International exhibits solutions to simplify the customer experience at ACT Expo 2025 “At International, we’re investing in innovative solutions to… Continue reading International Exhibits Solutions to Simplify the Customer Experience at ACT Expo 2025
German FAZ: Can BMW, Mercedes & Co. really keep up with BYD? 009237
They fight. Volkswagen, Mercedes and BMW are currently in China with full board strength, and the boardrooms in Germany are orphaned. China, the largest car market in the world, is a top priority. But after decades in which they dominated the market, the companies are in a deep identity crisis. This becomes clear at the… Continue reading German FAZ: Can BMW, Mercedes & Co. really keep up with BYD? 009237
German FAZ: Can BMW, Mercedes & Co. really keep up with BYD? 009237
They fight. Volkswagen, Mercedes and BMW are currently in China with full board strength, and the boardrooms in Germany are orphaned. China, the largest car market in the world, is a top priority. But after decades in which they dominated the market, the companies are in a deep identity crisis. This becomes clear at the… Continue reading German FAZ: Can BMW, Mercedes & Co. really keep up with BYD? 009237
Sunoco LP Announces a 1.25% Increase in Quarterly Distribution and Continues to Target 2025 Distribution Growth Rate of At Least 5%
DALLAS, April 23, 2025 /PRNewswire/ — Sunoco LP (NYSE: SUN) (“SUN” or the “Partnership”) announced that the Board of Directors of SUN’s general partner declared a distribution of $0.8976 per common unit, or $3.5904 on an annualized basis, for the quarter ended March 31, 2025. This represents an increase of approximately 1.25%, or $0.0111 per… Continue reading Sunoco LP Announces a 1.25% Increase in Quarterly Distribution and Continues to Target 2025 Distribution Growth Rate of At Least 5%
Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse Glioma
Statistically significant and clinically meaningful progression-free survival (PFS) and overall survival (OS) data for Zepzelca® (lurbinectedin) and atezolizumab (Tecentriq®) combination underscore potential of first-line maintenance therapy for extensive-stage small cell lung cancer, a much-needed advancement for patients Long-term outcomes and survival data for Ziihera® (zanidatamab-hrii) highlight its potential to reshape the treatment paradigm for newly diagnosed HER2+… Continue reading Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse Glioma
Veris Residential, Inc. Reports First Quarter 2025 Results
JERSEY CITY, N.J., April 23, 2025 /PRNewswire/ — Veris Residential, Inc. (NYSE: VRE) (the “Company”), a forward-thinking, Northeast-focused, Class A multifamily REIT, today reported results for the first quarter 2025. Three Months Ended March 31, 2025 2024 Net Income (loss) per Diluted Share $(0.12) $(0.04) Core FFO per Diluted Share $0.16 $0.14 Core AFFO per… Continue reading Veris Residential, Inc. Reports First Quarter 2025 Results